News

Tag: norepinephrine

Pharmacotherapy of Tobacco Use Disorder

In this lecture, Dr. Dugan discusses the history of tobacco use and reviews the medications that may be effective for smoking cessation. By the end of this lecture, you will be able to: 1) identify pharmacologic targets for treatment of tobacco use disorder, 2) list the adverse effects seen with pharmacologic treatment of tobacco use disorder, and 3) compare the efficacy data for agents used for treatment of tobacco use disorder.

Neurobiologically-Based Treatment of PTSD

Dr. Randy Welton discusses the neurobiological basis for PTSD and introduces treatments that address it. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.

Nicotine: Is It Good or Bad for People with Schizophrenia?

In this lecture, Dr. Dugan discusses the impact of nicotine on schizophrenia. By the end of this lecture, you will be able to: 1) describe the actions of nicotine on neurotransmitters, 2) list potential reasons for high use of nicotine products, specifically cigarettes in patients with schizophrenia, and 3) identify evidence of nicotine’s actions in patients with schizophrenia.

Amantadine: Mechanisms of Action and Potential Therapeutic Uses

In this lecture, Dr. Dugan examines some of the potential therapeutic uses for amantadine, explains its mechanisms of action, and reviews potential risks. By the end of this lecture, you will be able to: 1) describe the mechanism of action of amantadine, 2) list the adverse effects associated with the use of amantadine, and 3) identify uses for amantadine in patients with mental health conditions.

MAO Inhibitors. How Do These Antidepressants Work and How to Use Them Safely

In this lecture, Dr. Dugan explains how the MAO inhibitors work and the mechanisms behind the potential risks. She also discusses the therapeutic benefits of these medications and how to use them safely. By the end of this lecture, you will be able to: 1) describe the mechanism of action of the monoamine oxidase inhibitors (MAOIs), 2) identify relevant interactions of MAOIs with medications and foods, and 3) evaluate efficacy data of MAOIs in treatment of depression.

 

Tricyclic Antidepressants: An Overview

In this lecture, Dr. Dugan discusses the tricyclic antidepressants including their mechanism of action, indications, dosing, monitoring, and common side effects. By the end of this lecture, you will be able to: 1) describe the pharmacology of the tricyclic antidepressants (TCA), 2) identify relevant pharmacokinetic differences between TCAs, and 3) evaluate the literature on TCAs for the treatment of depression.

 

© 2024 Northeast Ohio Medical University | 4209 State Route 44, PO Box 95, Rootstown, Ohio 44272

ADA Compliance | Title IX | Privacy statement | Required document plugins